Sreeni Labs

Hyderabad, India
Contract research, development, and manufacturing services for global pharma, biotech, agro, and specialty chemicals sectors.

About Sreeni Labs

Sreeni Labs is a Healthcare company based in Hyderabad (India). Contract research, development, and manufacturing services for global pharma, biotech, agro, and specialty chemicals sectors. It operates in the Healthcare and Chemicals & Materials sectors. The company has 21 employees. Its Indian entity Sreeni Labs Private Limited reported revenue of β‚Ή14.05 Cr. Sreeni Labs offers products and services including Contract Research and Pharma Intermediates. Its focus areas include Pharmaceuticals, Contract Research, Drug Development and Chemicals.

Company details

Sreeni Labs was established in 2007 and is based in Hyderabad, Telangana, India, serving as a contract research, development, and manufacturing company. It is recognized for addressing the needs of global pharma, virtual biotech, agro, and specialty chemicals entities through innovative chemistry services. The company is equipped with advanced facilities, including 50 fume hoods and state-of-the-art equipment, to facilitate sustainable and cost-effective processes. Its efforts are directed towards advancing discovery and development programs while ensuring environmentally friendly practices are maintained.

  • Headquarters Hyderabad, India
  • Employees 21
  • Sectors
    Healthcare
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Social LinkedIn
  • Legal Name Sreeni Labs Private Limited
  • Date of Incorporation 17 May, 2007
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹14.05 Cr

    FY 2025 · -22% YoY

  • Net Profit
    ₹82.6 Lakh

    FY 2025 · 6% margin

  • EBITDA
    ₹1.92 Cr

    FY 2025 · 14% margin

  • Employee Count
    21

Products & Services of Sreeni Labs

Sreeni Labs offers a comprehensive portfolio of products and services, including Contract Research and Pharma Intermediates.

Contract Research
Research Services

Contract research services are provided for synthetic, medicinal, and process chemistry to support drug discovery and development programs.

Pharma Intermediates
Chemical Products

Manufacturing of pharma intermediates such as ethyl isocyano acetate and potassium isocyanoacetate is conducted for various industry needs.

Board of directors of Sreeni Labs Private Limited (Sreeni Labs)

Sreeni Labs Private Limited is the primary company behind Sreeni Labs. The board of Sreeni Labs Private Limited currently have 3 directors; the longest-serving is Sreenivasa Reddy Mundla, appointed in 2007. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sreenivasa Reddy Mundla
DIN 02305102
Managing Director27 Aug 200719 yrs 1 moSreeni Labs Private Limited
Mundla Padma Rekha
DIN 01815046
Director01 Oct 200719 yrsSreeni Labs Private Limited
Nagapratik Reddy Mundla
DIN 10393039
Director17 Nov 20232 yrs 11 moSreeni Labs Private Limited

Financials of Sreeni Labs

Figures of Sreeni Labs Private Limited, the primary company behind Sreeni Labs, for FY 2025. Revenue was ₹14.05 Cr (-22% year on year). Net profit was ₹82.6 Lakh (6% margin). EBITDA was ₹1.92 Cr (14% margin). Revenue has grown at a compounded annual rate of +12% over three years and +18% over five years.

  • ₹14.05 CrRevenue · FY 2025 · -22% YoY
  • ₹82.6 LakhNet profit · 6% margin
  • ₹1.92 CrEBITDA · 14% margin
  • ₹50 LakhPaid-up capital
  • 21Employees (provident fund records)
  • +12%Revenue CAGR, 3 years
  • +18%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Sreeni Labs Private Limited are on its company page.

Premium access

Detailed financial statements for Sreeni Labs

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Sreeni Labs

Sreeni Labs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Sreeni Labs has 21 employees.

The primary company behind Sreeni Labs, Sreeni Labs Private Limited, reported revenue of β‚Ή14.05 Cr for FY 2025, down 22% year on year.

Sreeni Labs was established in 2007 and is based in Hyderabad, Telangana, India, serving as a contract research, development, and manufacturing company. It is recognized for addressing the needs of global pharma, virtual biotech, agro, and specialty chemicals entities through innovative chemistry services. The company is equipped with advanced facilities, including 50 fume hoods and state-of-the-art equipment, to facilitate sustainable and cost-effective processes. Its efforts are directed towards advancing discovery and development programs while ensuring environmentally friendly practices are maintained.

Sreeni Labs offers Contract Research and Pharma Intermediates.

Sreeni Labs operates through Sreeni Labs Private Limited.

The legal entities of Sreeni Labs currently have 3 directors, including Sreenivasa Reddy Mundla, Mundla Padma Rekha, Nagapratik Reddy Mundla.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available